These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 1862731

  • 1. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Mellergård M, Lorentzen K, Bech P, Ottosson JO, Rosenberg R.
    Acta Psychiatr Scand Suppl; 1991; 365():28-32. PubMed ID: 1862731
    [Abstract] [Full Text] [Related]

  • 2. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of panic disorder patients responding to placebo.
    Rosenberg NK, Mellergård M, Rosenberg R, Beck P, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():33-8. PubMed ID: 1862732
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A.
    Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
    [Abstract] [Full Text] [Related]

  • 9. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R, Maier W, Goldenberg IM, Lavori PW, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(3):163-8. PubMed ID: 1827602
    [Abstract] [Full Text] [Related]

  • 10. Patterns of response during placebo treatment of panic disorder.
    Mellergård M, Rosenberg NK.
    Acta Psychiatr Scand; 1990 Apr; 81(4):340-4. PubMed ID: 2188481
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The sequence of improvement of the symptoms encountered in patients with panic disorder.
    Deltito JA, Argyle N, Buller R, Nutzinger D, Ottosson JO, Brandon S, Mellergard M, Shera D.
    Compr Psychiatry; 1991 Apr; 32(2):120-9. PubMed ID: 2022110
    [Abstract] [Full Text] [Related]

  • 17. The structure of phobias in panic disorder.
    Argyle N, Solyom C, Solyom L.
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [Abstract] [Full Text] [Related]

  • 18. Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
    Albus M, Maier W, Shera D, Bech P.
    Eur Arch Psychiatry Clin Neurosci; 1990 Sep; 240(2):96-102. PubMed ID: 2149655
    [Abstract] [Full Text] [Related]

  • 19. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB, Laraia MT, Ballenger JC, Howell EF.
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [Abstract] [Full Text] [Related]

  • 20. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
    Rickels K, Schweizer E, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.